Pokaż uproszczony rekord

dc.contributor.authorKorszun, Joanna
dc.date.accessioned2021-09-30T17:13:05Z
dc.date.available2021-09-30T17:13:05Z
dc.date.issued2021-09-29
dc.identifier.issn1730-2366
dc.identifier.urihttp://hdl.handle.net/11089/39282
dc.language.isoen
dc.publisherWydawnictwo Uniwersytetu Łódzkiegopl
dc.relation.ispartofseriesActa Universitatis Lodziensis. Folia Biologica et Oecologicaen
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.titleThe development of multidrug resistance in cancer cells: the potential of ABC transporter-targeted therapy to overcome inefficiency of treatmenten
dc.typeArticle
dc.page.number7-8
dc.contributor.authorAffiliationUniversity of Lodz, Faculty of Biology and Environmental Protection, Department of General Biophysics, Pomorska 141/143, 90-236 Lodz, Polanden
dc.identifier.eissn2083-8484
dc.referencesAdamska, A., Falasca, M. 2018. ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward? World Journal of Gastroenterology, 24(29): 3222–3238.en
dc.referencesBegicevic, R.R., Falasca, M. 2017. ABC transporters in cancer stem cells: Beyond chemoresistance. International Journal of Molecular Sciences, 18(11): 2362.en
dc.referencesBloise, E., Ortiga-Calvalho, T.M., Reis, F.M., Lye, S.J., Gibb, W., Matthews, S.G. 2016. ATP-binding cassette transporters in reproduction: A new frontier. Human Reproduction Update, 22(2): 164–181.en
dc.referencesChoi, Y., Yu, A. 2014. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. Current Pharmaceutical Design, 20(5), 793–807.en
dc.referencesDantzic, D., Noel, P., Merien, F., Liu, D-X., Lu, J., Han, H., McKeage, M.J., Li, Y. 2018. The effects of synthetically modified natural compounds on ABC transporters. Pharmaceutics, 10(3): 127.en
dc.referencesFultang, N., Illendula, A., Lin, J., Pandey, M.K., Klase, Z., Peethambaran, B. 2020. ROR1 regulates chemoresistance in breast cancer via modulation of drug efflux pump ABCB1. Scientific Reports, 10(1): 1821.en
dc.referencesGoldstein, L.J. 1995. Clinical reversal of drug resistance. Current Problems in Cancer, 19(2): 65–124.en
dc.referencesGomez-Zepeda, D., Taghi, M., Scherrmann, J-M., Decleves, X., Menet, M-C. 2020. ABC transporters at the blood-brain interfaces, their study models, and drug delivery implications in gliomas. Pharmaceutics, 12(1): 20.en
dc.referencesJanmaat, V.T., Steyerberg, E.W., van der Gast, A., Mathijssen, R., Bruno, M.J., Peppelenbosch, M.P., Kuipers, E.J., Spaander, M. 2017. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. Cochrane Database of Systematic Reviews, 11(11): CD004063.en
dc.referencesKim, K., Khang, D. 2020. Past, present, and future of anticancer nanomedicine. International Journal of Nanomedicine, 15: 5719–5743.en
dc.referencesKoh, J., Itahana, Y., Mendenhall, I.H., Low, D., Soh, E.X.Y., Guo, A.K., Chionh, Y.T., Wang, L-F., Itahana, K. 2019. ABCB1 protects bat cells from DNA damage induced by genotoxic compounds. Nature Communications, 10: 2820.en
dc.referencesTrock, B.J., Leonessa, F., Clarke, R. 1997. Multidrug resistance in breast cancer: A meta-analysis of MDR1/Gp170 expression and its possible functional significance. Journal of the National Cancer Institute, 89(13): 917–931.en
dc.referencesWu, S., Fu, L. 2018. Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells. Molecular Cancer, 7(1): 25.en
dc.contributor.authorEmailjoanna.korszun@edu.uni.lodz.pl
dc.identifier.doi10.18778/1730-2366.16.04
dc.relation.volume17


Pliki tej pozycji

Thumbnail

Pozycja umieszczona jest w następujących kolekcjach

Pokaż uproszczony rekord

https://creativecommons.org/licenses/by-nc-nd/4.0
Poza zaznaczonymi wyjątkami, licencja tej pozycji opisana jest jako https://creativecommons.org/licenses/by-nc-nd/4.0